← Eichor
Condition: Red Blood Cell Transfusion Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Red Blood Cell Transfusion

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Individualized ANH for Non-cardiac Surgery
NA · 1 location(s) · West China Hospital · NCT06399536
Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients
NA · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06060639
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functi
NA · 1 location(s) · University of Washington · NCT06710418
Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS
Phase N/A · 1 location(s) · Fundación para la Investigación Biosanitaria del Principado · NCT06614595
Red Blood Cell Transfusion in ECMO - A Feasibility Trial
NA · 2 location(s) · Australian and New Zealand Intensive Care Research Centre · NCT05814094
The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery
NA · 4 location(s) · Population Health Research Institute · NCT06230198
Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06721455
Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery a
Phase 1 · 2 location(s) · Jose Cancelas · NCT07446647
RH Genotype Matched RBC Transfusions
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT04156893
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Si
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06944067
Transfusion-Related Changes in Oxidative Stress Biomarkers in Neonates
Phase N/A · 1 location(s) · Medical University of Graz · NCT07672275
Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding
NA · 1 location(s) · Donald Arnold · NCT06947044
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Phase 2 · 26 location(s) · Celgene · NCT04143724
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Phase 3 · 13 location(s) · University of Alabama at Birmingham · NCT05638581
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel
Phase 3 · 156 location(s) · Takeda · NCT07422480
grouP O wholE blooD : storagE leSion impacT And infLammation
NA · 1 location(s) · Etablissement Français du Sang · NCT06809010
The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06012760
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant t
Phase 2 · 23 location(s) · Associazione Qol-one · NCT05924100
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
Phase 1 · 1 location(s) · James Reynolds · NCT03999229
Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion
NA · 1 location(s) · Hemanext · NCT06685848
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Phase 1/Phase 2 · 1 location(s) · Paul Szabolcs · NCT03653338
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
NA · 12 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06560164
Blood Warming in Preterm Infants to Decrease Hypothermia
NA · 1 location(s) · University of South Carolina · NCT05170633
Blood Storage Related Mortality and Adverse Effects in Trauma Patients
Phase N/A · 1 location(s) · Kocaeli City Hospital · NCT07341139
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient D
Phase 1 · 2 location(s) · Apriligen, Inc. · NCT07476183
Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes
Phase 4 · 8 location(s) · Michelle Zeller · NCT06840756
Allo HSCT for High Risk Hemoglobinopathies
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT06872333
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415
Hemoglobin Levels for Blood Transfusions During and After Surgery
NA · 1 location(s) · Ottawa Hospital Research Institute · NCT06718439
WithHolding Enteral Feeds Around Blood Transfusion (International)
NA · 40 location(s) · IWK Health Centre · NCT05213806
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.